SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
21832229
Source:
http://linkedlifedata.com/resource/pubmed/id/21832229
Search
Subject
(
50
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C1366903
,
umls-concept:C1619738
pubmed:issue
11
pubmed:dateCreated
2011-9-13
pubmed:abstractText
To study the outcome of patients with multiple sclerosis (MS) and with natalizumab-associated progressive multifocal leukoencephalopathy (PML) and immune reconstitution inflammatory syndrome (IRIS).
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/1P30MH075673
,
http://linkedlifedata.com/resource/pubmed/grant/R01NS056884
,
http://linkedlifedata.com/resource/pubmed/grant/UL1RR025005
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21832229-21832217
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized
,
http://linkedlifedata.com/resource/pubmed/chemical/natalizumab
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1526-632X
pubmed:author
pubmed-author:CaoZ KZK
,
pubmed-author:CliffordD BDB
,
pubmed-author:MajorE OEO
,
pubmed-author:McArthurJ CJC
,
pubmed-author:NathAA
pubmed:issnType
Electronic
pubmed:day
13
pubmed:volume
77
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1061-7
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:21832229-Adult
,
pubmed-meshheading:21832229-Aged
,
pubmed-meshheading:21832229-Antibodies, Monoclonal
,
pubmed-meshheading:21832229-Antibodies, Monoclonal, Humanized
,
pubmed-meshheading:21832229-Cohort Studies
,
pubmed-meshheading:21832229-Female
,
pubmed-meshheading:21832229-Humans
,
pubmed-meshheading:21832229-Immune Reconstitution Inflammatory Syndrome
,
pubmed-meshheading:21832229-Leukoencephalopathy, Progressive Multifocal
,
pubmed-meshheading:21832229-Male
,
pubmed-meshheading:21832229-Middle Aged
,
pubmed-meshheading:21832229-Plasmapheresis
,
pubmed-meshheading:21832229-Retrospective Studies
pubmed:year
2011
pubmed:articleTitle
Immune reconstitution inflammatory syndrome in natalizumab-associated PML.
pubmed:affiliation
Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
pubmed:publicationType
Journal Article
,
Comparative Study
,
Research Support, N.I.H., Extramural